Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209456
Status:
COMPLETED
Last Update Posted:
2007-05-16
First Post:
2005-09-13
Brief Title:
Dopamine Transporter Scintigraphy Imaging DAT-Imaging in Patients With Lewy Body Dementia
Sponsor:
GE Healthcare
Organization:
GE Healthcare
Study Overview
Official Title:
GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is designed to determine the diagnostic efficacy of the visual assessment of SPECT scans in differentiating between probable dementia with Lewy Bodies DLB and non-DLB dementia subjects determined by the clinical diagnosis of an independent expert consensus panel used as the standard of truth
Detailed Description:
GEHC had decided notto provide this detail
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None